Post-translational modifications of adiponectin: Mechanisms and functional implications

Biochemical Journal

Volumn 409, Issue 3, 2008, Pages 623-633

  Wang, Yu ^a,b   Lam, Karen S L ^a,b   Yau, Ming Hon ^a,b   Xu, Aimin ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adipokine; Adiponectin; Insulin sensitivity; Metabolic syndrome; Obesity

Indexed keywords

DISEASES; HYDROXYLATION; MOLECULAR MASS; MOLECULAR STRUCTURE; OLIGOMERS; TISSUE;

ADIPOKINE; ADIPONECTIN; INSULIN SENSITIVITY; METABOLIC SYNDROME;

DRUG PRODUCTS;

ADIPOCYTOKINE; ADIPONECTIN; INSULIN; OLIGOMER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE;

CYTOKINE RELEASE; GLYCOSYLATION; HUMAN; HYDROXYLATION; INSULIN SENSITIVITY; MOLECULAR BIOLOGY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; RNA TRANSLATION; SEX DIFFERENCE;

ADIPONECTIN; ANIMALS; HUMANS; PPAR GAMMA; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 38949125405     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20071492     Document Type: Review

References (102)

1. Shoelson, S. E., Herrero, L. and Naaz, A. (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132, 2169-2180
2. Trujillo, M. E. and Scherer, P. E. (2005) Adiponectin: journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J. Intern. Med. 257, 167-175
3. Hu, E., Liang, P. and Spiegelman, B. M. (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697-10703
4. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y. and Matsubara, K. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 221, 286-289
5. Nakano, Y., Tobe, T., Choi-Miura, N. H., Mazda, T. and Tomita, M. (1996) Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. (Tokyo) 120, 803-812
6. Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. and Lodish, H. F. (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746-26749
7. Ohashi, K., Kihara, S., Ouchi, N., Kumada, M., Fujita, K., Hiuge, A., Hibuse, T., Ryo, M., Nishizawa, H., Maeda, N. et al. (2006) Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47, 1108-1116
8. Okamoto, Y., Kihara, S., Ouchi, N., Nishida, M., Arita, Y., Kumada, M., Ohashi, K., Sakai, N., Shimomura, I., Kobayashi, H. et al. (2002) Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106, 2767-2770
9. Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. and Cooper, G. J. (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112, 91-100
10. Shibata, R., Sato, K., Pimentel, D. R., Takemura, Y., Kihara, S., Ohashi, K., Funahashi, T., Ouchi, N. and Walsh, K. (2005) Adiponectin protects against myocardial ischemia-repertusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 11, 1096-1103
11. Shore, S. A., Terry, R. D., Flynt, L., Xu, A. and Hug, C. (2006) Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J. Allergy Clin. Immunol. 118, 389-395
12. Wang, Y., Lam, J. B., Lam, K. S., Liu, J., Lam, M. C., Hoo, R. L., Wu, D., Cooper, G. J. and Xu, A. (2006) Adiponectin modulates the glycogen synthase kinase-3β/β-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res. 66, 11462-11470
13. Wang, Y., Lam, K. S. and Xu, A. (2007) Adiponectin as a negative regulator in obesity-related mammary carcinogenesis. Cell Res. 17, 280-282
14. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K. and Tobe, K. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116, 1784-1792
15. Wu, X., Motoshima, H., Mahadev, K., Stalker, T. J., Scalia, R. and Goldstein, B. J. (2003) Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52, 1355-1363
16. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K. et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295
17. Tsao, T. S., Tomas, E., Murrey, H. E., Hug, C., Lee, D. H., Ruderman, N. B., Heuser, J. E. and Lodish, H. F. (2003) Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways. J. Biol. Chem. 278, 50810-50817
18. Shibata, R., Ouchi, N., Ito, M., Kihara, S., Shiojima, I., Pimentel, D. R., Kumada, M., Sato, K., Schiekofer, S., Ohashi, K. et al. (2004) Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 10, 1384-1389
19. Wang, Y., Lam, K. S., Chan, L., Chan, K. W., Lam, J. B., Lam, M. C., Hoo, R. C., Mak, W. W., Cooper, G. J. and Xu, A. (2006) Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J. Biol. Chem. 281, 16391-16400
20. Cheng, K. K., Lam, K. S., Wang, Y., Huang, Y., Carling, D., Wu, D., Wong, C. and Xu, A. (2007) Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 56, 1387-1394
21. Kubota, N., Yano, W., Kubota, T., Yamauchi, T., Itoh, S., Kumagai, H., Kozono, H., Takamoto, I., Okamoto, S., Shiuchi, T. et al. (2007) Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 6, 55-68
22. Mao, X., Kikani, C. K., Riojas, R. A., Langlais, P., Wang, L., Ramos, F. J., Fang, Q., Christ-Roberts, C. Y., Hong, J. Y., Kim, R. Y. et al. (2006) APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell Biol. 8, 516-523
23. Oh, D. K., Ciaraldi, T. and Henry, R. R. (2007) Adiponectin in health and disease. Diabetes Obes. Metab. 9, 282-289
24. Trujillo, M. E. and Scherer, P. E. (2006) Adipose tissue-derived factors: impact on health and disease. Endocr. Rev. 27, 762-778
25. Wang, Y., Xu, A., Knight, C., Xu, L. Y. and Cooper, G. J. (2002) Hydroxylation and glycosylate of the four conserved lysine residues in the collagenous domain of adiponectin: potential role in the modulation of its insulin-sensitizing activity. J. Biol. Chem. 277, 19521-19529
26. Wang, Y., Lu, G., Wong, W. P., Vliegenthart, J. F., Gerwig, G. J., Lam, K. S., Cooper, G. J. and Xu, A. (2004) Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum. Proteomics 12, 3933-3942
27. Richards, A. A., Stephens, T., Charlton, H. K., Jones, A., Macdonald, G. A., Prins, J. B. and Whitehead, J. P. (2006) Adiponectin multimerisation is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerisation by alterations in post-translational modifications. Mol. Endocrinol. 20, 1673-1687
28. Passoja, K., Rautavuoma, K., Ala-Kokko, L., Kosonen, T. and Kivirikko, K. I. (1998) Cloning and characterization of a third human lysyl hydroxylase isoform. Proc. Natl. Acad. Sci. U.S.A. 95, 10482-10486
29. Wang, C., Luosujarvi, H., Heikkinen, J., Risteli, M., Uitto, L. and Myllyla, R. (2002) The third activity for lysyl hydroxylase 3: galactosylation of hydroxylysyl residues in collagens in vitro. Matrix Biol. 21, 559-566
30. Hug, C., Wang, J., Ahmad, N. S., Bogan, J. S., Tsao, T. S. and Lodish, H. F. (2004) T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl. Acad. Sci. U.S.A. 101, 10308-10313
31. Sato, C., Yasukawa, Z., Honda, N., Matsuda, T. and Kitajima, K. (2001) Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue-specific glycoprotein, adipo Q. J. Biol. Chem. 276, 28849-28856
32. Tsao, T. S., Murrey, H. E., Hug, C., Lee, D. H. and Lodish, H. F. (2002) Oligomerization state-dependent activation of NF-κB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J. Biol. Chem. 277, 29359-29362
33. Waki, H., Yamauchi, T., Kamon, J., Ito, Y., Uchida, S., Kita, S., Hara, K., Hada, Y., Vasseur, F., Froguel, P. et al. (2003) Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J. Biol. Chem. 278, 40352-40363
34. Xu, A., Chan, K. W., Hoo, R. L., Wang, Y., Tan, K. C., Zhang, J., Chen, B., Lam, M. C., Tse, C., Cooper, G. J. and Lam, K. S. (2005) Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J. Biol. Chem. 280, 18073-18080
35. Shapiro, L. and Scherer, P. E. (1998) The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 8, 335-338
36. Pajvani, U. B., Du, X., Combs, T. P., Berg, A. H., Rajala, M. W., Schulthess, T., Engel, J., Brownlee, M. and Scherer, P. E. (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: implications for metabolic regulation and bioactivity. J. Biol. Chem. 278, 9073-9085
37. Wang, Y., Lam, K. S., Xu, J. Y., Lu, G., Xu, L. Y., Cooper, G. J. and Xu, A. (2005) Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization dependent manner. J. Biol. Chem. 280, 18341-18347
38. Suzuki, S., Wilson-Kubalek, E. M., Wert, D., Tsao, T. S. and Lee, D. H. (2007) The oligomeric structure of high molecular weight adiponectin. FEBS Lett. 581, 809-814
39. Pajvani, U. B., Hawkins, M., Combs, T. P., Rajala, M. W., Doebber, T., Berger, J. P., Wagner, J. A., Wu, M., Knopps, A., Xiang, A. H. et al. (2004) Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279, 12152-12162
40. Kobayashi, H., Ouchi, N., Kihara, S., Walsh, K., Kumada, M., Abe, Y., Funahashi, T. and Matsuzawa, Y. (2004) Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 94, e27-e31
41. Ebinuma, H., Miyazaki, O., Yago, H., Hara, K., Yamauchi, T. and Kadowaki, T. (2006) A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin. Chim. Acta 372, 47-53
42. Ebinuma, H., Miida, T., Yamauchi, T., Hada, Y., Hara, K., Kubota, N. and Kadowaki, T. (2007) Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid. Clin. Chem. 53, 1541-1544
43. Nakano, Y., Tajima, S., Yoshimi, A., Akiyama, H., Tsushima, M., Tanioka, T., Negoro, T., Tomita, M. and Tobe, T. (2006) A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J. Lipid Res. 47, 1572-1582
44. Basu, R., Pajvani, U. B., Rizza, R. A. and Scherer, P. E. (2007) Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 56, 2174-2177
45. Bobbert, T., Rochlitz, H., Wegewitz, U., Akpulat, S., Mai, K., Weickert, M. O., Mohlig, M., Pfeiffer, A. F. and Spranger, J. (2005) Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 54, 2712-2719
46. Salani, B., Briatore, L., Andraghetti, G., Adami, G. F., Maggi, D. and Cordera, R. (2006) High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. Obesity 14, 1511-1514
47. Swarbrick, M. M., Austrheim-Smith, I. T., Stanhope, K. L., Van Loan, M. D., Ali, M. R., Wolfe, B. M. and Havel, P. J. (2006) Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery. Diabetologia 49, 2552-2558
48. Wang, Z. V., Schraw, T. D., Kim, J. Y., Khan, T., Rajala, M. W., Follenzi, A. and Scherer, P. E. (2007) Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol. Cell. Biol. 27, 3716-3731
49. Lara-Castro, C., Luo, N., Wallace, P., Klein, R. L. and Garvey, W. T. (2006) Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55, 249-259
50. Araki, S., Dobashi, K., Kubo, K., Asayama, K. and Shirahata, A. (2006) High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J. Clin. Endocrinol. Metab. 91, 5113-5116
51. Wang, A. Y., Hickman, I. J., Richards, A. A., Whitehead, J. P., Prins, J. B. and Macdonald, G. A. (2005) High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection. Am. J. Gastroenterol. 100, 2717-2723
52. Liu, Y., Retnakaran, R., Hanley, A., Tungtrongchit, R., Shaw, C. and Sweeney, G. (2007) Total and high molecular weight (HMW) but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. J. Clin. Endocrinol. Metab. 92, 4313-4318
53. Hara, K., Horikoshi, M., Yamauchi, T., Yago, H., Miyazaki, O., Ebinuma, H., Imai, Y., Nagai, R. and Kadowaki, T. (2006) Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29, 1357-1362
54. Torigoe, M., Matsui, H., Ogawa, Y., Murakami, H., Murakami, R., Cheng, X. W., Numaguchi, Y., Murohara, T. and Okumura, K. (2007) Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men. Clin. Endocrinol. 67, 276-281
55. Retnakaran, R., Connelly, P. W., Maguire, G., Sermer, M., Zinman, B. and Hanley, A. J. (2007) Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes. Diabetes Med. 24, 245-252
56. Nakashima, R., Kamei, N., Yamane, K., Nakanishi, S., Nakashima, A. and Kohno, N. (2006) Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J.Clin. Endocrinol. Metab. 91, 3873-3877
57. Inoue, T., Kotooka, N., Morooka, T., Komoda, H., Uchida, T., Aso, Y., Inukai, T., Okuno, T. and Node, K. (2007) High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am. J. Cardiol. 100, 569-574
58. Berg, A. H., Combs, T. P., Du, X., Brownlee, M. and Scherer, P. E. (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947-953
59. Kubota, N., Terauchi, Y., Kubota, T., Kumagai, H., Itoh, S., Satoh, H., Yano, W., Ogata, H., Tokuyama, K., Takamoto, I. et al. (2006) Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J. Biol. Chem. 281, 8748-8755
60. Nawrocki, A. R., Rajala, M. W., Tomas, E., Pajvani, U. B., Saha, A. K., Trumbauer, M. E., Pang, Z., Chen, A. S., Ruderman, N. B., Chen, H. et al. (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor γ agonists. J. Biol. Chem. 281, 2654-2660
61. Neumeier, M., Sigruener, A., Eggenhofer, E., Weigert, J., Weiss, T. S., Schaeffler, A., Schlitt, H. J., Aslanidis, C., Piso, P., Langmann, T. et al. (2007) High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes. Biochem. Biophys. Res. Commun. 352, 543-548
62. Fruebis, J., Tsao, T. S., Javorschi, S., Ebbets-Reed, D., Erickson, M. R., Yen, F. T., Bihain, B. E. and Lodish, H. F. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U.S.A. 98, 2005-2010
63. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N. et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941-946
64. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M. et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769
65. Hada, Y., Yamauchi, T., Waki, H., Tsuchida, A., Hara, K., Yago, H., Miyazaki, O., Ebinuma, H. and Kadowaki, T. (2007) Selective purification and characterization of adiponectin multimer species from human plasma. Biochem. Biophys. Res. Commun. 356, 487-493
66. Kusminski, C. M., McTernan, P. G., Schraw, T., Kos, K., O'Hare, J. P., Ahima, R., Kumar, S. and Scherer, P. E. (2007) Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia 50, 634-642
67. Kim, J. Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G. et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117, 2621-2637
68. Chen, H., Montagnani, M., Funahashi, T., Shimomura, I. and Quon, M. J. (2003) Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 278, 45021-45026
69. Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., Kishida, K., Nishizawa, H. et al. (2001) Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103, 1057-1063
70. Ouedraogo, R., Wu, X., Xu, S. Q., Fuchsel, L., Motoshima, H., Mahadev, K., Hough, K., Scalia, R. and Goldstein, B. J. (2006) Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 55, 1840-1846
71. Neumeier, M., Weigert, J., Schaffler, A., Wehrwein, G., Muller-Ladner, U., Scholmerich, J., Wrede, C. and Buechler, C. (2006) Different effects of adiponectin isoforms in human monocytic cells. J. Leukocyte Biol. 79, 803-808
72. Matsuda, M., Shimomura, I., Sata, M., Arita, Y., Nishida, M., Maeda, N., Kumada, M., Okamoto, Y., Nagaretani, H., Nishizawa, H. et al. (2002) Role of adiponectin in preventing vascular stenosis: the missing link of adipo-vascular axis. J. Biol. Chem. 277, 37487-37491
73. Masaie, H., Oritani, K., Yokota, T., Takahashi, I., Shirogane, T., Ujiie, H., Ichii, M., Saitoh, N., Maeda, T., Tanigawa, R. et al. (2007) Adiponectin binds to chemokines via the globular head and modulates interactions between chemokines and heparan sulfates. Exp. Hematol. 35, 947-956
74. Peake, P. W., Shen, Y., Campbell, L. V. and Charlesworth, J. A. (2006) Human adiponectin binds to bacterial lipopolysaccharide. Biochem. Biophys. Res. Commun. 341, 108-115
75. Bub, J. D., Miyazaki, T. and Iwamoto, Y. (2006) Adiponectin as a growth inhibitor in prostate cancer cells. Biochem. Biophys. Res. Commun. 340, 1158-1166
76. Korner, A., Pazaitou-Panayiotou, K., Kelesidis, T., Kelesidis, I., Williams, C. J., Kaprara, A., Bullen, J., Neuwirth, A., Tseleni, S., Mitsiades, N. et al. (2007) Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J. Clin. Endocrinol. Metab. 92, 1041-1048
77. Peake, P. W., Hughes, J. T., Shen, Y. and Charlesworth, J. A. (2007) Glycosylation of human adiponectin affects its conformation and stability. J. Mol. Endocrinol. 39, 45-52
78. Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D. and Kahn, S. E. (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46, 459-469
79. Combs, T. P., Berg, A. H., Rajala, M. W., Klebanov, S., Iyengar, P., Jimenez-Chillaron, J. C., Patti, M. E., Klein, S. L., Weinstein, R. S. and Scherer, P. E. (2003) Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52, 268-276
80. Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., Matsuda, M., Kondo, H., Furuyama, N., Kihara, S. et al. (2002) Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51, 2734-2741
81. Bogan, J. S. and Lodish, H. F. (1999) Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4. J. Cell Biol. 146, 609-620
82. Andersen, K. K., Frystyk, J., Wolthers, O. D., Heuck, C. and Flyvbjerg, A. (2007) Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children. J. Clin. Endocrinol. Metab. 92, 1857-1862
83. Liu, P. Y., Death, A. K. and Handelsman, D. J. (2003) Androgens and cardiovascular disease. Endocr. Rev. 24, 313-340
84. Song, D., Arikawa, E., Galipeau, D., Battell, M. and McNeill, J. H. (2004) Androgens are necessary for the development of fructose-induced hypertension. Hypertension 43, 667-672
85. Imagawa, A., Funahashi, T., Nakamura, T., Moriwaki, M., Tanaka, S., Nishizawa, H., Sayama, K., Uno, S., Iwahashi, H., Yamagata, K. et al. (2002) Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 25, 1665-1666
86. Bluher, M., Michael, M. D., Peroni, O. D., Ueki, K., Carter, N., Kahn, B. B. and Kahn, C. R. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 3, 25-38
87. Semple, R. K., Soos, M. A., Luan, J., Mitchell, C. S., Wilson, J. C., Gurnell, M., Cochran, E. K., Gorden, P., Chatterjee, V. K., Wareham, N. J. and O'Rahilly, S. (2006) Elevated plasma adiponectin in humans with genetically defective insulin receptors. J. Clin. Endocrinol. Metab. 91, 3219-3223
88. Semple, R. K., Halberg, N. H., Burling, K., Soos, M. A., Schraw, T., Luan, J., Cochran, E. K., Dunger, D. B., Wareham, N. J., Scherer, P. E. et al. (2007) Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56, 1712-1717
89. Mohlig, M., Wegewitz, U., Osterhoff, M., Isken, F., Ristow, M., Pfeiffer, A. F. and Spranger, J. (2002) Insulin decreases human adiponectin plasma levels. Horm. Metab. Res. 34, 655-658
90. Fasshauer, M., Klein, J., Neumann, S., Eszlinger, M. and Paschke, R. (2002) Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 290, 1084-1089
91. Lam, K. S., Xu, A., Tan, K. C., Wong, L.-C. and Tam, S. C. (2004) Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. J. Clin. Endocrinol. Metab. 89, 5772-5778
92. Combs, T. P., Wagner, J. A., Berger, J., Doebber, T., Wang, W. J., Zhang, B. B., Tanen, M., Berg, A. H., O'Rahilly, S., Savage, D. B. et al. (2002) Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: a potential mechanism of insulin sensitization. Endocrinology 143, 998-1007
93. Hoo, R. L., Chow, W. S., Yau, M. H., Xu, A., Tso, A. W., Tse, H. F., Fong, C. H., Tam, S., Chan, L. and Lam, K. S. (2007) Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production. Arterioscler. Thromb. Vasc. Biol. 27, 2777-2782
94. Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N. et al. (2001) PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094-2099
95. Iwaki, M., Matsuda, M., Maeda, N., Funahashi, T., Matsuzawa, Y., Makishima, M. and Shimomura, I. (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52, 1655-1663
96. Bodles, A., Banga, A., Rasouli, N., Ono, F., Kern, P. A. and Owens, R. J. (2006) Pioglitazone increases secretion of high molecular weight adiponectin from adipocytes. Am. J. Physiol. Endocrinol. Metab. 291, E1100-E1105
97. Rasouli, N., Yao-Borengasser, A., Miles, L. M., Elbein, S. C. and Kern, P. A. (2006) Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression. Am. J. Physiol. Endocrinol. Metab. 290, E42-E46
98. Qiang, L., Wang, H. and Farmer, S. R. (2007) Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-Lα. Mol. Cell. Biol. 27, 4698-4707
99. Alberini, C. M., Bet, P., Milstein, C. and Sitia, R. (1990) Secretion of immunoglobulin M assembly intermediates in the presence of reducing agents. Nature 347, 485-487
100. Anelli, T., Alessio, M., Bachi, A., Bergamelli, L., Bertoli, G., Camerini, S., Mezghrani, A., Ruffato, E., Simmen, T. and Sitia, R. (2003) Thiol-mediated protein retention in the endoplasmic reticulum: the role of ERp44. EMBO J. 22, 5015-5022
101. Xie, L., Boyle, D., Sanford, D., Scherer, P. E., Pessin, J. E. and Mora, S. (2006) Intracellular trafficking and secretion of adiponectin is dependent on GGA-coated vesicles. J. Biol. Chem. 281, 7253-7259
102. Waki, H., Yamauchi, T., Kamon, J., Kita, S., Ito, Y., Hada, Y., Uchida, S., Tsuchida, A., Takekawa, S. and Kadowaki, T. (2005) Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146, 790-796